Hintergrund: Die Tumornekrosefaktoren alpha und beta (TNF-a, TNF-b) können eine Vielzahl von zellulären Vorgängen regulieren und unterstützen Tumorwachstum und -progression. Die Auswirkungen der Polymorphismen TNF-a-238G>A und TGF (transforming growth factor)-b1 L10P auf das Brustkrebsrisiko sind noch immer ungeklärt bzw. nicht eindeutig. 
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Summary Background: The tumor necrosis factors alpha and beta (TNF-a, TNF-b) can regulate a wide range of cellular responses and facilitate tumor growth and progression. However, the effects of the polymorphisms TNF-a-238G>A and transforming growth factor (TGF)-b1 L10P on breast cancer risk are still unclear or inconclusive.
Materials and Methods:
In order to provide a full estimation of the association with breast cancer, a metaanalysis of the most valid literature was performed by searching the databases PubMed, Web of Science, ScienceDirect, EBSCO, CNKI, and Google Scholar. Results: For TNF-a-238G>A, 3 studies including 35,578 cases and 38,095 controls were selected. For TGF-b1 L10P, 11 studies including 7,903 cases and 8,797 controls were selected. For TNF-a-238G>A, a significant association with breast cancer risk was found in the recessive model (odds ratio = 0.954, 95% confidence interval 0.912-0.998), but other models did not reach significance. For TGF-b1 L10P, no significant correlations were found. Conclusions: Our study indicates that TNF-a-238G>A may be associated with breast cancer incidence, although significance is weak. Its role as an indicator for cancer diagnosis should be studied more. Moreover, for TGF-b1 L10P, further comprehensive meta-analyses are necessary. lated literature for TNF-a-238G>A is not at all comprehensive based on our preliminary search of previous publications using the online scientific database PubMed. The present study provides the first detailed meta-analysis for TNF-a-308G/A and its association with breast cancer risk.
Transforming growth factor beta 1 (TGF-b1) is a potent inhibitor of proliferation of epithelial, endothelial and hematopoietic cells, and acts as a tumor suppressor [3] . However, TGF-b1 may facilitate tumor growth, as its overexpression can enhance tumor metastases [4] . The gene for TGF-b1 carries a common T/C variation of nucleotide 29, resulting in a leucine (L) to proline (P) polymorphism at codon 10 (TGFB1 L10P). Based on our literature search, no meta-analysis related to this position seems to have been carried out thus far.
In the present study, we review the literature on the 2 gene polymorphisms mentioned above in conjunction with breast cancer and offer a systematic meta-analysis of their association. The purpose of the study is to provide consistent evidence regarding the association of TGF-b1 L10P and TNF-a-238G>A with respect to breast cancer incidence.
Materials and Methods
Selection of Studies
The following databases or searching engines were used to search articles published online before January 2010: PubMed, Web of Science, ScienceDirect, EBSCO, CNKI, and Google Scholar. We used the terms 'TNFalpha', 'TNF-a', '238', '308', 'TGF', 'TGF-b1', 'L10P', and 'breast' to identify the studies closely related to TNF-a, TGF-b1, and breast cancer risk. References were double checked by different authors to identify any missing studies in the database search. Review articles were handsearched to find additional eligible references. Only published studies with available full text articles were included. When overlapping data of the same patient population were included in more than 1 publication, only the literature providing the full text was used in the analysis [2] .
Introduction
Breast cancer is by far the most prevailing cancer in women. It was the second leading cause of cancer deaths in the US in 2008, following lung cancer. The mechanisms underlying breast cancer are still far from fully understood. Many susceptibility genes combined with environmental factors have been suggested to be important in the growth and development of cancer.
Studies investigating the relationship between common genetic variants and cancer risk are being reported with rapidly increasing frequency [1] . In this study, we tried to combine previous individual articles to obtain more precise estimates of breast cancer risk. An important genetic variant for inhibiting cancer development and growth is the tumor necrosis factor alpha (TNF-a) which is a member of the TNF/TNF cytokine receptor superfamily and involved in the maintenance and homeostasis of the immune system, inflammation, and host defense. Although TNF-a was originally regarded to cause hemorrhagic tumor necrosis at high concentrations in many types of cancers, low concentrations of TNF-a seem to increase tumor growth and progression. Studies examining the role of the TNF-a gene in breast cancer growth have shown that TNF-a can serve as a breast tumor promoter. TNF-a is a widely studied factor associated with tumor development and growth. Single nucleotide polymorphisms of TNF-a have attracted much attention regarding their potential use as detection indicators for certain cancers. So far, the polymorphism TNF-a-238G>A, rs361525 has not been investigated and its relationship with cancer risk has not been understood compared to another important polymorphism, TNF-a-308G/A. In a recent study by Fang et al. [2] , the association between TNF-a-308G/A and breast tumor risk was confirmed through a meta-analysis. However, the accumu- Guo/Meng/Pei/Zhu tween TNF-a-238G>A and breast cancer risk in Asian women are warranted. Our results suggested that the influence of the individual data sets on OR estimation was significant. The cohort data from Gaudet et al. [6] is the most influential ( fig. 2 ). In addition, neither Begg's funnel plot nor Egger's test suggest any obvious evidences of publication bias (p > 0.05) ( fig. 3 ).
Statistical Analysis
We explored the association using an additive genetic model (for TNF-a: GG versus AA; for TGF-b1: TT versus CC), dominant model (for TNFa: GG+GA versus AA; for TGF-b1: TT+TC versus CC), recessive model (for TNF-a: GG versus GA+AA; for TGF-b1: TT versus TC+CC), and allele contrast (for TNF-a: G allele versus A allele; for TGF-b1: T allele versus C allele). Odds ratios (ORs) and 95% confidence intervals (CIs) were used to assess the strength of the association between a single nucleotide polymorphism and breast cancer risk. The inverse variance weighting method was used for pooling. The heterogeneity of the data was quantified using Q statistic. Heterogeneity among studies was considered significant when p was < 0.1 (Q statistic). If there was significant heterogeneity among studies, the random effects model was used, otherwise, the fixed effects model was acceptable. Publication bias was represented by funnel plots and was further assessed using Egger's linear regression test (p < 0.05 was considered representative of statistically significant publication bias). When there was a significant publication with regard to gene polymorphisms and breast cancer risk, the Duval and Tweedie non-parametric 'trim and fill' method was applied to correct the publication bias. All statistical analyses were performed with the software Stata 10 (StataCorp LP, College Station, Texas, USA).
Results and Discussion
Literature Characteristics
In total, 11 studies, comprising 12 data sets with 7,903 cases and 8,797 controls, were included based on the selection criteria for analyzing the susceptibility risk of TGF-b1 L10P. The data from Le Marchand et al. [5] can be divided into 2 parts, one for the Caucasian population and another for the Asian population. For TNF-a-238G>A, 3 studies, comprising 4 data sets with 35,578 cases and 38,095 controls, were identified for analyzing its connection with breast cancer susceptibility. Similarly, the cohort data from Gaudet et al. [6] can be divided into 2 subsets based on ethnicity, which will be evaluated further (tables 1 and 2).
Association between TNF-a-238G>A and Breast Cancer Risk
Significantly different breast cancer risk was found for the recessive model (GG versus GA+AA) ( fig. 1 ). After ethnic stratification (focusing on Caucasian), significant differences were no longer found, implying the importance of the Asian population (table 3) . However, since only 1 record was available for the Asian population, a validated meta-analysis cannot be guaranteed. Therefore, further studies on the association be- 
Association between TGF-b1 L10P and Breast Cancer Risk
We found no significant association between TGF-b1 L10P and breast cancer risk (table 4) with the random effects model. Although most genetic models present significant probabilities using the fixed effects model of meta-analysis, the results can still not be adopted rationally to reveal a relationship because the heterogeneity tests are significant (not shown). In the subsequent analysis based on ethnicity, no significant associations were found either.
Further Perspectives
There are still inconsistencies regarding TGF-b1 L10P and breast caner. Our work is congruent with the cohort study of Rebbeck et al. [7] . However, a recent meta-analysis by Qiu et al. [8] supports a positive association between TGF-b1 L10P and breast caner. This demonstrates that further evaluation of this gene polymorphism is necessary before a consensus can be reached.
A meta-analysis on TNF-a-238G>A has not been previously carried out. For the first time, our analysis confirmed that the TNF-a-238G>A is associated with breast cancer incidence, similar to TNF-a-308G/A [2] . However, because the literature on TNF-a-238G>A is still limited, the significance of the association is weak. Therefore, further studies on the application of TNF-a-238G>A as a clinical indicator are needed.
Overall, we attempted to reduce the lack of power exhibited by an individual study and combine different previous studies to perform a meta-analysis. We summarized the results of previous meta-analyses, and based on some new find- 
